IMPACT-PLuS follow-up found 80% of children treated with early-life peanut oral immunotherapy remained peanut tolerant 8 to 11 years later.
Jennifer A. Dantzer, MD, MHS
Advertisement
Jennifer A. Dantzer, MD, MHS, assistant professor of pediatrics, Johns Hopkins University School of Medicine.
Articles by Jennifer A. Dantzer, MD, MHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Pamufetinib Fails to Slow FVC Decline in Progressive Fibrosing ILD
2
FDA Accepts NDA for Ralinepag in Pulmonary Arterial Hypertension
3
Brensocatib Patient Selection Evolves 1 Year After FDA Approval
4
Allergists Debate: Which Nonsteroidal to Use for Atopic Dermatitis?
5